Risk of Hospitalization for Stroke Associated with Antipsychotic Use in the Elderly A Self-Controlled Case Series

被引:32
|
作者
Pratt, Nicole L. [1 ]
Roughead, Elizabeth E. [2 ]
Ramsay, Emmae [1 ]
Salter, Amy [1 ]
Ryan, Philip [1 ]
机构
[1] Univ Adelaide, Discipline Publ Hlth, Data Management & Anal Ctr, Adelaide, SA 5000, Australia
[2] Univ S Australia, Sch Pharm & Med Sci, Qual Use Med & Pharm Res Ctr, Sansom Inst, Adelaide, SA 5001, Australia
关键词
ATYPICAL ANTIPSYCHOTICS; CEREBROVASCULAR EVENTS; ALZHEIMERS-DISEASE; DEMENTIA; DEATH; POPULATION; DRUGS; METAANALYSIS; RISPERIDONE; PSYCHOSIS;
D O I
10.2165/11584490-000000000-00000
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Antipsychotics are commonly used in the elderly despite a lack of safety data from randomized trials, particularly for the typical antipsychotics Observational studies have investigated the association between antipsychotics and stroke but results vary, which may be due to lack of control for unmeasured confounding Objective To estimate the risk of hospitalization for stroke in elderly users of antipsychotics Study Design and Setting Using the Australian Government Department of Veterans' Affairs administrative claims dataset we utilized a self-controlled case series design to risk-adjust for potential unmeasured confounding Risk periods prior to antipsychotic initiation were also included to search for evidence of confounding by indication Unexposed patients were included to adjust for the increasing incidence of hospitalization for stroke with age Results There were 10 638 patients aged 65 years with at least one hospitalization for stroke identified during the 4-year period from 1 January 2003 to 31 December 2006 Of these, 514 patients were initiated on typical antipsychotics and 564 patients were initiated on atypical antipsychotics Hospitalization for stroke was increased in the first week after initiation of a typical antipsychotic (incidence rate ratio [IRR] 2 3, 95% CI 1 3, 3 8) There was no evidence of an increased risk of hospitalization for stroke after initiation of atypical antipsychotics The risk of hospitalization for stroke progressively increased in the weeks leading up to first-time antipsychotic treatment However, while the risk of hospitalization for stroke in the week prior to initiating antipsychotic therapy was significantly increased for patients initiated on typical antipsychotics (IRR 7 2, 95% CI 5 3, 9 8), patients initiated on atypical antipsychotics had no excess risk in the same period (IRR 1 2, 95% CI 0 7, 2 3) Conclusions The results of this study are consistent with randomized controlled trial evidence indicating that there is no Increased risk of serious cerebrovascular events requiring hospitalization in patients taking atypical antipsychotics No randomized controlled trial evidence is available on the risk of hospitalization for stroke with use of typical antipsychotics in the elderly This study found a small but significantly increased risk of hospitalization for stroke immediately following the initiation of typical antipsychotics Antipsychotics are likely to be initiated after hospitalization for stroke This practice is likely to reflect the prescribing of antipsychotics during hospital admission for post-stroke complications such as delirium, however, the long-term effects of this practice are unknown
引用
收藏
页码:885 / 893
页数:9
相关论文
共 50 条
  • [31] The methodology of self-controlled case series studies
    Whitaker, Heather J.
    Hocine, Mounia N.
    Farrington, C. Paddy
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2009, 18 (01) : 7 - 26
  • [32] Antipsychotics and the Risk of Hip Fracture, Pneumonia and Stroke: Self-Controlled Case Series and Instrumental Variable Analysis Results
    Pratt, Nicole
    Roughead, Elizabeth
    Ryan, Philip
    Peck, Robert
    Gilbert, Andrew
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S108 - S108
  • [33] Risk of Stroke after Herpes Zoster - Evidence from a German Self-Controlled Case-Series Study
    Schink, Tania
    Behr, Sigrid
    Thoene, Kathrin
    Bricout, Helene
    Garbe, Edeltraut
    PLOS ONE, 2016, 11 (11):
  • [34] Risk of fracture in antidepressant users with concurrent use of benzodiazepines: A self-controlled case-series analysis
    Yang, Bo Ram
    Lee, Eunchae
    Hwang, Beom Seuk
    Lee, Sung Hoon
    Kang, Ye-Jin
    Jung, Sun-Young
    BONE, 2021, 153
  • [35] Antibiotic Use and Risk of Microscopic Colitis in Older Adults: A Nationwide Self-Controlled Case Series Study
    Szilcz, Mate
    Ludvigsson, Jonas F.
    Johnell, Kristina
    Wastesson, Jonas W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 255 - 255
  • [36] Bisphosphonate Use May Be a Risk Factor for Osteonecrosis at Any Site: A Self-Controlled Case Series Analysis
    Vlad, Steven C.
    Zhu, Yanyan
    Niu, Jingbo
    Peloquin, Christine
    Choi, Hyon
    Zhang, Yuqing
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S118 - S119
  • [37] Antibiotic Use and Risk of Microscopic Colitis in Older Adults: A Nationwide Self-Controlled Case Series Study
    Szilcz, Mate
    Wastesson, Jonas W.
    Bergman, David
    Johnell, Kristina
    Ludvigsson, Jonas F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025,
  • [38] The use of case crossover and self-controlled case series studies in pharmacoepidemiology: A literature review
    Buysse, Brian
    Desai, Jayashri
    Sinclair, Susan
    Duncan, Julie
    Albano, Jessica
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 227 - 227
  • [39] The use of relative incidence ratios in self-controlled case series studies: an overview
    Steven Hawken
    Beth K. Potter
    Julian Little
    Eric I. Benchimol
    Salah Mahmud
    Robin Ducharme
    Kumanan Wilson
    BMC Medical Research Methodology, 16
  • [40] Risk of Suicidal Event with Stimulant Treatment: A Self-Controlled Case Series Study
    Man, Kenneth
    Coghill, David
    Chan, Esther
    Lau, Wallis
    Hollis, Chris
    Liddle, Elizabeth
    Banaschewski, Tobias
    McCarthy, Suzanne
    Neubert, Antje
    Sayal, Kapil
    Ip, Patrick
    Schuemie, Martijn
    Sturkenboom, Miriam
    Sonuga-Barke, Edmund
    Buitelaar, Jan
    Carucci, Sara
    Zuddas, Alessandro
    Kovshoff, Hanna
    Garas, Peter
    Nagy, Peter
    Inglis, Sarah
    Konrad, Kerstin
    Haege, Alexander
    Rosenthal, Eric
    Wong, Ian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 476 - 476